Caricamento...
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by symptoms of discomfort, decreased tear quality, and chronic inflammation that affects an estimated 20 million patients in the US alone. DED is associated with localized inflammation of the ocular surface and pe...
Salvato in:
| Pubblicato in: | Clin Ophthalmol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910612/ https://ncbi.nlm.nih.gov/pubmed/27354762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S110557 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|